Posts by Sandra Ansanay-Alex
Alliance, your partner for your Innosuisse application
You have an innovative project and are thinking of submitting an Innosuisse application? With its team of specialized advisors, Alliance is your ally! Between 2020 and 2021, the EPFL based association has raised over CHF 57 million for Swiss SMEs. What is Alliance and how was the structure created? Alliance is the technological innovation…
Read MoreDomo Health: a digital platform for home health
Lack of resources and staff, aging population, an increase in chronic diseases: the challenges of the medical world are numerous and the situations to be managed are increasingly complex. Domo Health develops a digital health platform powered by artificial intelligence. It collects, processes and analyses data from patients and healthcare professionals to optimise prevention, diagnosis,…
Read MoreGeNeuro starts a clinical trials for its long COVID treatment
200 patients are recruited and will be followed in 5 Swiss hospitals participating in the study. The first results are expected during the second semester 2023. GeNeuro is a biopharmaceutical company developing new treatments for neurodegenerative and autoimmune diseases such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS) and the severe consequences of…
Read MoreProf. Antoine Geissbuhler elected at the Royal Academy of Medicine of Belgium
A new mission for BioAlps’ President Professor at the Department of Radiology and Medical Informatics of the Faculty of Medicine, Vice-Rector of the UNIGE and Head of the e-Health and Telemedicine Service of the University Hospitals of Geneva, and newly appointed “Foreign Corresponding Member” of the Royal Academy of Medicine of Belgium. Trained as…
Read MoreSymbios opens a new factory in Yverdon
The 12 000 m2 facility will be ready next spring in the Y-Parc in Yverdon-les-Bains. Leader in the production of custom-made orthopedic prostheses, Symbios plans to double its turnover in five years. To compete with the American giants that dominate the orthopedic prosthesis market, Symbios has been banking on technological innovation since 1989. “We are…
Read MoreVolumina Medical Gets a CHF 500 000 Loan from FIT
Volumina Medical is an EPFL spin-off based in Biopôle Lausanne. The company develops a biogel that supports the repair of soft tissues. Volumina Medical is developing highly innovative biomaterials for regenerative medicine. Their solutions address high unmet needs for the markets of reconstructive and plastic surgery. Volumina’s first product is Adipearl, a leading innovative…
Read MoreSwitzerland sets to accept medical devices with FDA approval
The Federal Council is to adapt national laws so that, in addition to medical devices with an EU certificate / CE mark, medical devices with U.S. Food & Drug Administration (FDA) approval will now also be recognised in Switzerland. Although not an EU member state or even part of the European Economic Area, Switzerland…
Read MoreEUR 3.7 million for ONWARD and its partners from the European Innovation Council (EIC)
The European Innovation Council Grant has been awarded to ONWARD and its research partners, including EPFL, IICT-BAS, CEA-Leti-Clinatec, and CEAList. The company also received the First Place Winner of the 2022 Brain-Computer Interface (BCI) Award. ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in…
Read MoreLimula wins the start-up Swiss Technology Award
During the Swiss Innovation Forum on 23 November 2022 in Basel, Limula won the Inventor Award. Two other companies were also awarded: Sevensense Robotics an ETH Zürich spin-off that wants to make delivery robots autonomous, got the start-up award. And Schleuniger Group got the Industry Innovation Award. Precision medicine made affordable Limula is…
Read MoreCERN, CHUV and THERYQ develop a revolutionary FLASH radiotherapy device to fight cancer
This FLASH radiotherapy device will use very high-energy electrons (VHEE) to treat cancers that are resistant to conventional treatments, with greatly reduced side effects. The device is the first of its kind. Based on CERN technology, it will be installed at CHUV when ready. This collaboration between CERN, CHUV and THERYQ is another example…
Read More